ARCHIVES

FDA developing guidelines for oncology endpoints.

This article is from The Cancer Letter archive.

Vol. 30 No. 19 | May 7, 2004

Download PDF Visit The Full Archive

Related Articles

DCDDP Final Report; 3,557 Cancers, 90% By Mammography

July 9, 1982

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992

Henschke and Supporters Call For Urgent Action Based On Results Of NLST

May 13, 2011

Other Institutes Fare Well With ’77 Appropriations

August 20, 1976

Weicker Negotiating For 6,000 NIH Grants In Both 1985, 1986; Societies Appeal For Adequate Funding

May 10, 1985

Cervarix Vaccine Approved To Prevent Cervical Cancer

October 30, 2009